Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-027003)

Filing Details

Accession Number:: 0001209191-17-027003
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2017-04-14 18:44:17
Reporting Period:: 2017-04-11

Filing Date:: 2017-04-14
Accepted Time:: 2017-04-14 18:44:17
Original Submission Date:: 2017-04-11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1269021	Portola Pharmaceuticals Inc	PTLA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1574558	William Lis	C/O Portola Pharmaceuticals, Inc. 270 East Grand Ave. South San Francisco CA 94080	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-04-11	6,750	$36.06	4,730	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This amendment is being filed for the purpose of providing a correction to footnote 1 of the original, which is now restated as footnote 2 to this filing.
The sale reported on this Form 4 was effected for the purpose of tax withholding in connection with the vesting of Restricted Stock Units and was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2017 and amended on March 21, 2017.